110 related articles for article (PubMed ID: 20819084)
1. The hypothetical role of FoxO1 in acne is interesting, but more study is needed before any conclusions can be drawn.
Leyden JJ; Gollnick H; Thiboutot D; Dreno B; Bettoli V; Kang S; Shalita A; Torres V
Br J Dermatol; 2010 Dec; 163(6):1365-6; author reply 1366-7. PubMed ID: 20819084
[No Abstract] [Full Text] [Related]
2. Is nuclear deficiency of FoxO1 due to increased growth factor/PI3K/Akt-signalling in acne vulgaris reversed by isotretinoin treatment?
Melnik BC
Br J Dermatol; 2010 Jun; 162(6):1398-400. PubMed ID: 20394627
[No Abstract] [Full Text] [Related]
3. Adverse effects of isotretinoin therapy for acne vulgaris.
Lamb SR; Oakley AM
N Z Med J; 2001 Sep; 114(1139):414. PubMed ID: 11665936
[No Abstract] [Full Text] [Related]
4. Severe acne infantum successfully treated with isotretinoin.
Torrelo A; Pastor MA; Zambrano A
Pediatr Dermatol; 2005; 22(4):357-9. PubMed ID: 16060877
[TBL] [Abstract][Full Text] [Related]
5. The role of transcription factor FoxO1 in the pathogenesis of acne vulgaris and the mode of isotretinoin action.
Melnik BC
G Ital Dermatol Venereol; 2010 Oct; 145(5):559-71. PubMed ID: 20930691
[TBL] [Abstract][Full Text] [Related]
6. Successful isotretinoin treatment of acne in a patient with Apert syndrome.
Dolenc-Voljc M; Finzgar-Perme M
Acta Derm Venereol; 2008; 88(5):534-5. PubMed ID: 18779907
[No Abstract] [Full Text] [Related]
7. Psychological impact of isotretinoin treatment in patients with moderate and severe acne.
Simić D; Situm M; Letica E; Penavić JZ; Zivković MV; Tomić T
Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines for the good use of isotretinoin in private practice: a prospective observational study of 1263 acne patients].
Jeanmougin M; Beaulieu P; Doutre MS; Jaramillo C
Ann Dermatol Venereol; 2009 Jan; 136(1):54-6. PubMed ID: 19171232
[No Abstract] [Full Text] [Related]
9. Isotretinoin in acne agminata.
Daneshpazhooh M; Ehsani A; Toosi S; Robati RM
Saudi Med J; 2007 Oct; 28(10):1600-2. PubMed ID: 17914528
[TBL] [Abstract][Full Text] [Related]
10. Isotretinoin in Denmark -- 20 years on.
Wildfang IL; Nielsen NH; Jemec GB; Ibsen HH; Avnstorp C
J Dermatolog Treat; 2002 Sep; 13(3):151-2. PubMed ID: 12227880
[No Abstract] [Full Text] [Related]
11. Myths of isotretinoin therapy in patients with acne: a personal opinion.
Alcalay J
J Drugs Dermatol; 2004; 3(2):179-82. PubMed ID: 15098974
[TBL] [Abstract][Full Text] [Related]
12. Depression is not common in isotretinoin-treated acne patients.
Rohrback JM; Fleischer AB; Krowchuk DP; Feldman SR
J Dermatolog Treat; 2004 Jul; 15(4):252. PubMed ID: 15764041
[No Abstract] [Full Text] [Related]
13. Successful treatment of acne with isotretinoin in chronic granulomatous disease.
Barbi E; Berti I; Minute M; Zennaro F
Eur J Dermatol; 2011; 21(1):111-2. PubMed ID: 21224185
[No Abstract] [Full Text] [Related]
14. Isotretinoin dosing: past, present, and future trends.
Hirsch RJ; Shalita AR
Semin Cutan Med Surg; 2001 Sep; 20(3):162-5. PubMed ID: 11594671
[TBL] [Abstract][Full Text] [Related]
15. A practical approach for the use of oral isotretinoin for infantile acne.
Barnes CJ; Eichenfield LF; Lee J; Cunningham BB
Pediatr Dermatol; 2005; 22(2):166-9. PubMed ID: 15804310
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and treatment of acne.
Bogal CB
Adv Nurse Pract; 2010 Apr; 18(4):22. PubMed ID: 20486299
[No Abstract] [Full Text] [Related]
17. In Brief: Absorica for acne.
Med Lett Drugs Ther; 2013 Jan; 55(1407):8. PubMed ID: 24892143
[No Abstract] [Full Text] [Related]
18. Evaluation of depressive symptoms in acne patients treated with isotretinoin.
Bozdağ KE; Gülseren S; Güven F; Cam B
J Dermatolog Treat; 2009; 20(5):293-6. PubMed ID: 19701845
[TBL] [Abstract][Full Text] [Related]
19. Safe usage of isotretinoin in a woman with latent acute intermittent porphyria.
Storjord E; Brekke OL; Nielsen EW
Acta Derm Venereol; 2007; 87(3):267-8. PubMed ID: 17533497
[No Abstract] [Full Text] [Related]
20. Body dysmorphic disorder of twins with facial illness after successful isotretinoin therapy.
Erkolahti R; Ilonen T; Eerola M; Saarijärvi S; Majamaa H
Acta Derm Venereol; 2004; 84(6):499-500. PubMed ID: 15844656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
